NervGen Pharma Corp. (TSXV:NGEN)
Canada · Delayed Price · Currency is CAD 3.900
+0.080 (2.09%)
Oct 24, 2025, 2:00 PM EDT
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of CAD 280.42 million as of October 24, 2025. Its market cap has increased by 65.78% in one year.
Market Cap
280.42M
Enterprise Value
264.80M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.90
Market Cap Chart
Since March 15, 2019, NervGen Pharma's market cap has increased from 50.07M to 280.42M, an increase of 460.04%. That is a compound annual growth rate of 29.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 280.42M | 27.02% |
| Dec 31, 2024 | 220.77M | 37.18% |
| Dec 29, 2023 | 160.94M | 71.42% |
| Dec 30, 2022 | 93.89M | -24.19% |
| Dec 31, 2021 | 123.84M | 58.14% |
| Dec 31, 2020 | 78.31M | 36.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.22B |
| Green Thumb Industries | 2.63B |
| dentalcorp Holdings | 2.17B |
| Trulieve Cannabis | 2.15B |
| Sienna Senior Living | 1.82B |
| Cronos Group | 1.35B |
| Extendicare | 1.29B |
| WELL Health Technologies | 1.26B |